Advertisement

Topics

EF Johnson Technologies, Inc. Company Profile

17:03 EDT 18th September 2018 | BioPortfolio

Headquartered in Irving, Texas, EF Johnson Technologies, Inc. focuses on innovating, developing and marketing the highest quality secure communications solutions to organizations whose mission is to protect and save lives. The Company's customers include first responders in public safety and public service, the federal government, and industrial organizations. The Company's products are marketed under the EFJohnson, 3e Technologies International, and Transcrypt International names and are Made in America. For more information, visit http://www.EFJohnsonTechnologies.com.


News Articles [846 Associated News Articles listed on BioPortfolio]

Johnson & Johnson Medical acquires Emerging Implant Technologies

Based in Wurmlingen, Germany, Emerging Implant Technologies (EIT) is a privately held manufacturer of 3D-printed titanium interbody implants for spinal fusion surgery. The company is claimed to be Th...

Johnson & Johnson Posting Notable Loss But Well Off Lows

NEW BRUNSWICK (dpa-AFX) - Shares of Johnson & Johnson (JNJ) have climbed well off their worst levels of the day but remain in negative territory in late-day trading on Friday. Johnson & Johnson is...

Johnson & Johnson verkauft Desinfektionssparte für 2,7 Milliarden Dollar: Johnson & Johnson steigt aus ...

Johnson & Johnson steigt aus dem Geschäft für Sterilisationsprodukte aus: Die Sparte übernimmt der Konzern Fortive für 2,7 Milliarden Dollar.Der Pharma- und Konsumgüterkonzern Johnson & Johnson (...

Forbidden Technologies plc: Von Johnson Associates, Inc. ...

LONDON and LOS ANGELES, September 5, 2018 /PRNewswire/ -- Forbidden Technologies plc has announced that Von Johnson & Associates, Inc. (VJA) has selected and is Read more...

After rebates, Johnson & Johnson says prices fell 4.6% last year

In a report highlighting the company’s record on corporate responsibility, Johnson & Johnson notes…

Change of CFO at Johnson & Johnson

After 19 years with the US healthcare giant Johnson & Johnson (NYSE: JNJ), Dominic Caruso, executive…

Johnson & Johnson erhält Kaufgebot für Blutzuckergeschäft

Von Cara Lombardo NEW YORK (Dow Jones)--Johnson & Johnson hat ein Übernahmegebot für sein Geschäft mit Geräten für die Kontrolle des Blutzuckerspiegels erhalten. Die Beteiligungsgesellschaft Plat...

Finanzinvestor buhlt um Diabetes-Tochter von Johnson & Johnson

LOS ANGELES/NEW BRUNSWICK (dpa-AFX)- Der US-Konzern Johnson & Johnson hat ein milliardenschweres Angebot für seinen Diabetesspezialisten LifeScan erhalten. Die Beteiligungsgesellschaft Platinum Eq...

PubMed Articles [364 Associated PubMed Articles listed on BioPortfolio]

Nursing care of a boy seriously infected with Steven-Johnson syndrome after treatment with azithromycin: A case report and literature review.

Stevens-Johnson syndrome (SJS) is an acute blistering disease of the skin and mucous membranes. SJS in children is not common but potentially serious disease. But the epidemiology of SJS in China is n...

Stevens-Johnson Syndrome: A Challenging Diagnosis.

Stevens-Johnson syndrome is a rare, yet life-threatening, delayed-type hypersensitivity reaction characterized by mucocutaneous epidermal necrolysis. Toxic epidermal necrolysis is a severe manifestati...

Life-threatening dermatoses: Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis. Impact on the Spanish public health system (2010-2015).

Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are serious mucocutaneous reactions. In Spain, the epidemiology and resulting expenses of these diseases are not well established.

Stevens-Johnson syndrome and toxic epidermal necrolysis-like cutaneous presentation of chikungunya fever: A case series.

Chikungunya fever is a benign, self-limiting, acute viral illness. An epidemic occurred in New Delhi, India, in August and September 2016. We observed many cases with atypical cutaneous features mimic...

Retrospective review of paediatric case reports of Stevens-Johnson syndrome and toxic epidermal necrolysis with lamotrigine from an international pharmacovigilance database.

This study aims to characterise paediatric reports with lamotrigine (LTG) and Stevens-Johnson syndrome or toxic epidermal necrolysis (SJS/TEN), and to explore whether potential risk factors can be ide...

Clinical Trials [474 Associated Clinical Trials listed on BioPortfolio]

Stevens-Johnson Syndrome Antimicrobial

Steven-Johnson's syndrome, or great multiform erythema, appears as a systemic disturbance, with skin involvement and mucous membranes, related to several factors, such as, viral or bacteri...

Phase III Clinical Trial of NPB-01 in Patients With Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis Unresponsive to Corticosteroids.

Patients diagnosed with Stevens-Johnson syndrome and Toxic Epidermal Necrolysis were confirmed based on the investigators national diagnostic criteria. Patients who meet all inclusion crit...

Extracorporeal Photopheresis Pilot Study

ECP will be given to the patients [UVAR®XTS TM Therakos system, Johnson & Johnson] according to the following schedule: Starting at day 21 after transplant, if hematologic recovery allow...

A Relative Bioavailability Study of 20 mg Famotidine Tablets Under Fed Condition

The study was conducted as an open-label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioavailability study comparing famotidine tablets, USP 20 ...

A Relative Bioavailability Study of 20 mg Famotidine Tablets Under Fasting Condition

The study was conducted as an open-label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioavailability study comparing famotidine tablets, USP 20 ...

Companies [1424 Associated Companies listed on BioPortfolio]

Johnson and Johnson

Johnson & Johnson, employing approximately 119,000 people worldwide, is engaged in the manufacture and sale of a broad range of products in the health care field in many countries of the world. Johnso...

Johnson & Johnson Innovation

The London Innovation Centre is part of Johnson & Johnson Innovation, a division of Johnson & Johnson Finance Limited. Johnson & Johnson Innovation focuses on accelerating early i...

Johnson & Johnson (China) Investment Co., Ltd.

Johnson & Johnson (China) Investment Co., Ltd. is a foreign investment entity established in China by Johnson & Johnson in 1998. For more information about Johnson & Johnson and its operating unit...

JOHNSON'S(R) Brand

JOHNSON'S® Brand from Johnson & Johnson Consumer Products Company, Division of Johnson & Johnson Consumer Companies, Inc., has a long tradition of providing pure, mild, gentle and clinically-proven p...

JANSSEN-ORTHO INC

Since 1961 Janssen-Cilag has been a member of the Johnson & Johnson family of companies. Founded in 1886, Johnson & Johnson today is the world's most comprehensive manufacturer of healthcare products ...

More Information about "EF Johnson Technologies, Inc." on BioPortfolio

We have published hundreds of EF Johnson Technologies, Inc. news stories on BioPortfolio along with dozens of EF Johnson Technologies, Inc. Clinical Trials and PubMed Articles about EF Johnson Technologies, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of EF Johnson Technologies, Inc. Companies in our database. You can also find out about relevant EF Johnson Technologies, Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record